Search results
Here's Why Eli Lilly Stock Remains a Screaming Buy
Motley Fool via Yahoo Finance· 7 hours agoThe Stock Advisor service has more than quadrupled the return of S&P...recommends Novo Nordisk. The Motley Fool has a disclosure policy. Here's Why Eli...
TIME100 Health: David Ricks
Time via Yahoo Finance· 4 hours agoThe U.S. Food and Drug Administration (FDA) approved Lilly...treatment, similar to the way cancers are treated. That would be
Why Eli Lilly's earnings are no sure thing for traders despite obesity drug momentum
CNBC· 3 days agoEli Lilly appears to be making as much of its popular obesity and diabetes medicines as it can, but...
Eli Lilly assures investors it can overcome the high-quality problem of too much demand
CNBC· 2 days agoEli Lilly Why we own it: Eli Lilly's best-in-class drugs should enable growth above the industry ...
Lilly Soars as Forecast Boost Shows Weight-Loss Drugs’ Power
Bloomberg via Yahoo Finance· 2 days ago(Bloomberg) -- Eli Lilly & Co.’s shares soared as its brighter outlook for 2024 raised the potential...
Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
Associated Press via Yahoo Finance· 2 days agoRapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro,...
Eli Lilly Just Announced More Good News: Time to Buy?
Motley Fool via Yahoo Finance· 4 days agoS. who need more time to look into the clinical trials Eli Lilly used to support the therapy's...
Chiquita Brooks-LaSure
Time Magazine· 4 hours agoS. health care system. The Centers for Medicare and Medicaid Services (CMS) has been both criticized—for its requirements for covering a new Alzheimer...
Eli Lilly (LLY) Q1 Earnings Top, Sales Miss, 2024 View Raised
Zacks via Yahoo Finance· 2 days agoEli Lilly (LLY) beats first-quarter estimates for earnings but misses the same for sales. It raises...
The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology via Yahoo Finance· 9 hours agoThis will allow the company to enhance its next-generation drug discovery capabilities in oncology and more specifically solid tumours....
